NCT02010541

Brief Summary

The first purpose of this study is to is to compare metabolic control of type 1 diabetes among children under the age of 7 years who use an insulin pump and a real-time (RT) glucose sensor, and children who use only insulin pump; the investigators will also determine dietary habits, their knowledge of type 1 diabetes management and emotional aspects of experiencing illness in the family, in both groups of children.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

December 9, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 12, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
Last Updated

February 13, 2014

Status Verified

February 1, 2014

Enrollment Period

4 months

First QC Date

December 9, 2013

Last Update Submit

February 12, 2014

Conditions

Keywords

type 1 diabetes among young children, sensor, insulin pump, education, psychological support

Outcome Measures

Primary Outcomes (1)

  • Glycaemic control

    We will determine HbA1c, average blood glucose, number of blood glucose readings/use of sensors, average AUC for sensor users, readings above and under target for both groups at the beginning and afer 3 months.

    3 months

Secondary Outcomes (1)

  • knowledge on diet and diabetes management

    3 months

Other Outcomes (2)

  • Number of adverse events

    3 months

  • Quality of Life measures

    3 months

Study Arms (2)

insulin pump group

20 children below the age of 7 years who use an insulin pump for at least 6 months, more than 6 months of duration of type 1 diabetes, complete remission, no associated disease (normal blood pressure for age, only therapy insulin).

RT (real time) -CGMS group

20 children below the age of 7 years who use an insulin pump and RT-CGMS on regular basis for at least 6 months, more than 6 months of duration of type 1 diabetes, complete remission, no associated disease (normal blood pressure for age, only therapy insulin). pump for at least 6 months, and children below the age of 7 years who use RT-CGMS on regular

Eligibility Criteria

AgeUp to 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All children that have diabetes in Slovenia are controlled at the Dept. of Pediatric Endocrinology, Diabetes \& Metabolism, University Children's Hospital, UMCL and the population will be taken from here

You may qualify if:

  • age up to 7 years
  • insulin pump for at least 6 months
  • more than 6 months of duration of type 1 diabetes
  • complete remission
  • normal blood pressure for age, only therapy insulin.

You may not qualify if:

  • age over 8 years
  • type 1 diabetes less than 6 months
  • insulin pump less than 6 months
  • still in remission
  • associated diseases on drug therapy, high blood pressure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of Pediatric Endocrinology, Diabetes & Metabolism, University Children's Hospital, UMCL

Ljubljana, 1000, Slovenia

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Tadej Battelino

    Dept. of Pediatric Endocrinology, Diabetes & Metabolism, University Children's Hospital, UMCL

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head, Dept. of Pediatric Endocrinology, Diabetes & Metabolism, University Children's Hospital, UMCL

Study Record Dates

First Submitted

December 9, 2013

First Posted

December 12, 2013

Study Start

December 1, 2013

Primary Completion

April 1, 2014

Study Completion

May 1, 2014

Last Updated

February 13, 2014

Record last verified: 2014-02

Locations